UPC APP 68655/2024

—

Verfahrensdetails: Status
—
Verfahrensart
Verfahrensantrag
Kategorie
Rücknahmeanträge
Parteien: Kläger
DexCom, Inc.
Vertreter: Anne-Charlotte le Bihan (Bird & Bird LLP); Laurent Labatte (Bird & Bird LLP); David Sproston (Hoffmann Eitle); Mark Jones (Hoffmann Eitle)
Beklagte
Abbott Laboratories
Abbott Diabetes Care Inc.
Abbott GmbH
Abbott Diagnostics GmbH
Abbott Logistics B.V.
Abbott (S.A./N.V.)
Abbott s.r.l.
Abbott B.V.
Abbott Scandinavia Aktiebolag
Abbott France (S.A.S.)
Division: Court of Appeal
Richter: —
Sprache: —
Erste Entscheidung: 24. Jan. 2025

Entscheidungen

2025-01-24
ZurückgenommenApplication Rop 265
The Court of Appeal allowed DexCom's withdrawal of its infringement action and Abbott's withdrawal of the counterclaims for revocation, declared the proceedings closed, and ordered reimbursement of 60% of DexCom's court fees; as a result the first instance decision revoking DexCom's patent became ineffective.
Rechtsfragen:Withdrawal of infringement action on appeal (R. 265 RoP)Effect of withdrawal on prior revocation decisionReimbursement of court fees (R. 370.9 RoP)

Dokumente